AEON Biopharma Inc.

0.75
0.02 (2.74%)
At close: Mar 18, 2025, 3:59 PM
0.74
-1.05%
After-hours: Mar 18, 2025, 08:00 PM EDT

AEON Biopharma Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 5.16M 9.75M 5.13M 20.17M 6.32M
Short-Term Investments n/a n/a n/a n/a 105.42M
Long-Term Investments n/a n/a n/a n/a 1.43M
Other Long-Term Assets 29K 34K 360K 838K 778K
Receivables n/a n/a n/a n/a 267K
Inventory n/a n/a n/a n/a n/a
Other Current Assets 1.06M 92K 26K 208K 133K
Total Current Assets 6.22M 9.84M 5.15M 20.38M 112.14M
Property-Plant & Equipment 594K 906K 922K n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 623K 940K 1.28M 838K 2.21M
Total Assets 6.84M 10.78M 6.44M 21.21M 114.35M
Account Payables 3.39M 7.8M 1.19M 2.03M 1.02M
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt 278K 71.12M 15.6M n/a 14.79M
Other Current Liabilities 8.81M 3.65M 4.01M 2.17M 1.68M
Total Current Liabilities 13.05M 82.57M 20.8M 4.2M 17.5M
Long-Term Debt n/a 60.67M 71.29M 72.16M 15.16M
Other Long-Term Liabilities 146.84M 137.95M 138.17M 148.09M 147.56M
Total Long-Term Liabilities 146.84M 198.62M 209.46M 220.25M 162.73M
Total Liabilities 159.89M 281.19M 230.26M 224.45M 180.22M
Total Debt 278K 131.53M 86.89M 72.16M 29.95M
Common Stock 4K 14K 14K 11K 11K
Retained Earnings -473.6M -474.84M -422.28M -366.65M -333.73M
Comprehensive Income n/a n/a n/a n/a n/a
Shareholders Equity -153.04M -287.5M -234.94M -208.27M -67.15M
Total Investments n/a n/a n/a n/a 106.85M